Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
12.85
+0.12 (0.94%)
Nov 21, 2024, 4:00 PM EST - Market closed

Pliant Therapeutics Revenue

In the year 2023, Pliant Therapeutics had annual revenue of $1.58M, down -83.69%.

Revenue (ttm)
$1.58M
Revenue Growth
-83.69%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
158
Market Cap
781.97M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.58M-8.11M-83.69%
Dec 31, 20229.69M2.11M27.91%
Dec 31, 20217.57M-34.25M-81.89%
Dec 31, 202041.82M-15.24M-26.70%
Dec 31, 201957.05M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.12B
Pacira BioSciences 694.96M
Avanos Medical 681.50M
Evolus 248.33M
Cytek Biosciences 201.21M
Avid Bioservices 142.36M
Cronos Group 111.23M
Autolus Therapeutics 10.09M
Revenue Rankings